News
DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. DSP develops, produces and sells intermediates, active pharmaceutical ...
DSM Sinochem Pharmaceuticals, global leader in sustainable antibiotics, in collaboration with the Indian Institute of Technology, New Delhi organized a workshop today on 'Sustainability through ...
Shares in DSM <DSMN.AS> rise 2.8 percent after the Dutch chemicals and life sciences group said Chinese oil and chemicals firm Sinochem would pay 210 million euros for a 50 percent stake in DSM's ...
Royal DSM NV, the world’s biggest vitamin maker, sold a 50 percent stake in its penicillin operation to Sinochem Group for 210 million euros ($279 million), ending a six year search for a partner.
DSM Sinochem Pharmaceuticals (DSP), the global leader in production and commercialization of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has ...
Chinese oil and chemicals firm Sinochem said on Friday it will pay 210 million euros ($278.1 million) for a 50 percent stake in the anti-infectives business of Dutch life sciences firm Royal DSM ...
Serving the chemical, life science, and laboratory worlds ...
China's state-owned Sinochem Group announced it has reached a framework agreement Friday with the Netherlands-based Royal DSM N.V. to buy a 50-percent stake in DSM's anti-infectives unit.
The name, resulting from a change in ownership, reflects its role at the centre of modern healthcareROTTERDAM, Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Effective December 10, 2018 Centrient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results